Noevir Holdings Co., Ltd. (TYO:4928)

Revenue by Segment

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Cosmetics	50.53B	49.76B	48.18B	47.03B	38.33B
Cosmetics Growth	1.54%	3.29%	2.43%	22.72%	-1.08%
Other	2.93B	2.89B	2.67B	2.97B	2.09B
Other Growth	1.28%	8.43%	-10.11%	42.08%	0.24%
Pharmaceuticals & Health Food	11.54B	11.44B	11.99B	11.41B	11.12B
Pharmaceuticals & Health Food Growth	0.80%	-4.52%	5.06%	2.62%	-1.38%
Unallocated Adjustment	-266.00M	-275.00M	-276.00M	-265.00M	-260.00M
Total	64.72B	63.82B	62.55B	61.14B	51.27B
Total Growth	1.41%	2.03%	2.30%	19.25%	-1.10%

Revenue by Geography

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Japan	64.72B	63.82B	62.55B	61.14B	51.27B
Japan Growth	1.41%	2.03%	2.30%	19.25%	-1.10%
Total	64.72B	63.82B	62.55B	61.14B	51.27B
Total Growth	1.41%	2.03%	2.30%	19.25%	-1.10%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 14, 2026

Data Sources Report a data error